Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8904309rdf:typepubmed:Citationlld:pubmed
pubmed-article:8904309lifeskim:mentionsumls-concept:C0007600lld:lifeskim
pubmed-article:8904309lifeskim:mentionsumls-concept:C1314972lld:lifeskim
pubmed-article:8904309lifeskim:mentionsumls-concept:C0005953lld:lifeskim
pubmed-article:8904309lifeskim:mentionsumls-concept:C0162597lld:lifeskim
pubmed-article:8904309lifeskim:mentionsumls-concept:C0376152lld:lifeskim
pubmed-article:8904309lifeskim:mentionsumls-concept:C0237497lld:lifeskim
pubmed-article:8904309lifeskim:mentionsumls-concept:C0185023lld:lifeskim
pubmed-article:8904309lifeskim:mentionsumls-concept:C1947904lld:lifeskim
pubmed-article:8904309lifeskim:mentionsumls-concept:C2698172lld:lifeskim
pubmed-article:8904309lifeskim:mentionsumls-concept:C1708533lld:lifeskim
pubmed-article:8904309lifeskim:mentionsumls-concept:C1999228lld:lifeskim
pubmed-article:8904309lifeskim:mentionsumls-concept:C2825781lld:lifeskim
pubmed-article:8904309pubmed:issue2lld:pubmed
pubmed-article:8904309pubmed:dateCreated1997-4-1lld:pubmed
pubmed-article:8904309pubmed:abstractTextIn this study, we report on the cell adhesion properties of marrow stromal cells to extracellular matrix components such as collagen and noncollagenous proteins. The osteoblastic cells and their non-osteoblastic counter-parts (MBA series) from the marrow stroma differentially recognized a spectrum of extracellular matrix proteins. The osteoblastic cells, MBA-15, preferentially attached to bone matrix proteins, whereas fibroendothelial MBA-2.1 and adipocytic 14F1.1 cells did not. The MBA-15 cells demonstrated a preference in their attachment to fibronectin > mixture of collagens > bone matrix extracts > collagen type I > noncollagenous proteins. Clonal subpopulations derived from the MBA-15 cell line representing various stages along the osteogenic lineage expressed differential attachment preference. MBA-15.4, a less differentiated clonal line, was compared to MBA-15.6, a mature cell line.lld:pubmed
pubmed-article:8904309pubmed:languageenglld:pubmed
pubmed-article:8904309pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8904309pubmed:citationSubsetIMlld:pubmed
pubmed-article:8904309pubmed:statusMEDLINElld:pubmed
pubmed-article:8904309pubmed:monthOctlld:pubmed
pubmed-article:8904309pubmed:issn0730-2312lld:pubmed
pubmed-article:8904309pubmed:authorpubmed-author:FriedAAlld:pubmed
pubmed-article:8904309pubmed:authorpubmed-author:RobeyP GPGlld:pubmed
pubmed-article:8904309pubmed:authorpubmed-author:WientroubSSlld:pubmed
pubmed-article:8904309pubmed:authorpubmed-author:BenayahuDDlld:pubmed
pubmed-article:8904309pubmed:authorpubmed-author:EfratyMMlld:pubmed
pubmed-article:8904309pubmed:issnTypePrintlld:pubmed
pubmed-article:8904309pubmed:volume59lld:pubmed
pubmed-article:8904309pubmed:ownerNLMlld:pubmed
pubmed-article:8904309pubmed:authorsCompleteYlld:pubmed
pubmed-article:8904309pubmed:pagination151-60lld:pubmed
pubmed-article:8904309pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8904309pubmed:meshHeadingpubmed-meshheading:8904309-...lld:pubmed
pubmed-article:8904309pubmed:meshHeadingpubmed-meshheading:8904309-...lld:pubmed
pubmed-article:8904309pubmed:meshHeadingpubmed-meshheading:8904309-...lld:pubmed
pubmed-article:8904309pubmed:meshHeadingpubmed-meshheading:8904309-...lld:pubmed
pubmed-article:8904309pubmed:meshHeadingpubmed-meshheading:8904309-...lld:pubmed
pubmed-article:8904309pubmed:meshHeadingpubmed-meshheading:8904309-...lld:pubmed
pubmed-article:8904309pubmed:meshHeadingpubmed-meshheading:8904309-...lld:pubmed
pubmed-article:8904309pubmed:meshHeadingpubmed-meshheading:8904309-...lld:pubmed
pubmed-article:8904309pubmed:meshHeadingpubmed-meshheading:8904309-...lld:pubmed
pubmed-article:8904309pubmed:meshHeadingpubmed-meshheading:8904309-...lld:pubmed
pubmed-article:8904309pubmed:meshHeadingpubmed-meshheading:8904309-...lld:pubmed
pubmed-article:8904309pubmed:meshHeadingpubmed-meshheading:8904309-...lld:pubmed
pubmed-article:8904309pubmed:year1995lld:pubmed
pubmed-article:8904309pubmed:articleTitleBone marrow interface: preferential attachment of an osteoblastic marrow stromal cell line.lld:pubmed
pubmed-article:8904309pubmed:affiliationDepartment of Cell Biology and Histology, Division of Orthopaedics, Sackler School of Medicine, Tel-Aviv University, Israel.lld:pubmed
pubmed-article:8904309pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8904309pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:8904309pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed